These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32223656)
1. Beyond type 2 cytokines in asthma - new insights from old clinical trials. Choy DF; Arron JR Expert Opin Ther Targets; 2020 May; 24(5):463-475. PubMed ID: 32223656 [No Abstract] [Full Text] [Related]
2. Mechanisms in allergic airway inflammation - lessons from studies in the mouse. Shum BO; Rolph MS; Sewell WA Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727 [TBL] [Abstract][Full Text] [Related]
5. Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma. Lin SC; Shi LS; Ye YL Cells; 2019 Jul; 8(7):. PubMed ID: 31284537 [TBL] [Abstract][Full Text] [Related]
7. New insights into the role of cytokines in asthma. Renauld JC J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111 [TBL] [Abstract][Full Text] [Related]
17. Basophils and mast cells in airway inflammation and asthma. Denburg JA Can Respir J; 1998; 5 Suppl A():41A-4A. PubMed ID: 9753516 [TBL] [Abstract][Full Text] [Related]
18. Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases. Gubernatorova EO; Namakanova OA; Gorshkova EA; Medvedovskaya AD; Nedospasov SA; Drutskaya MS Front Immunol; 2021; 12():601842. PubMed ID: 34084159 [TBL] [Abstract][Full Text] [Related]
19. Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far? Parulekar AD; Diamant Z; Hanania NA Curr Opin Pulm Med; 2017 Jan; 23(1):3-11. PubMed ID: 27820746 [TBL] [Abstract][Full Text] [Related]
20. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]